drugset / Trial / NCT00993707
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
Phase 2
Completed
11 enrolled
Turino, Gerard, M.D.
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the safety of administering repeated doses of CTX-100 (formerly ETX-100) to subjects with smoking-related chronic obstructive pulmonary disease.
Timeline
- Start
- 2010-11
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hyaluronic Acid | Other / unclassified | 0.01 % | Inhaled |
| Comparator | Hyaluronic Acid | Other / unclassified | 0.03 % | Inhaled |